Hybrid Complete Protection Flourescence Molecular Tomography and X-ray CT
Hybrid Complete Protection Flourescence Molecular Tomography and X-ray CT
批准号:
7415088
负责人:
RALPH WEISSLEDER, MD, PHD
金额:
$36.74万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2010-05-31
关键词:
AccountingAlgorithmsAnimalsArtsAttentionBasic ScienceCell physiologyChimeric ProteinsCollectionDataData SetDependenceDepthDetectionDevelopmentDiffuseDimensionsDiseaseEngineeringFeasibility StudiesFiberFluorescenceFluorescent DyesFluorochromeGenerationsGenomicsGoalsHeterogeneityHybridsImageImageryImaging TechniquesImaging technologyLightingLiquid substanceMalignant NeoplasmsMethodsModalityMolecularMolecular ProbesNumbersOptical TomographyOpticsPerformancePhotonsPrincipal InvestigatorProceduresPropertyProteinsProteomicsPublicationsReportingResolutionSamplingSchemeScienceSignal TransductionSmall Animal Imaging SystemsSourceSurfaceSystemTechnologyTestingThree-Dimensional ImageTimeTissuesWeightX-Ray Computed TomographyX-Ray Tomographyanimal tissuebasecharge coupled device cameradesigndrug discoveryfluorescence imaginggene functionimprovedin vivointerestmolecular imagingmouse modelnext generationnovelnovel strategiesoptical imagingphysical modelpre-clinicalpreclinical studyprogramsprototypereconstructiontissue processingtomographytreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The increasing availability of powerful fluorescent agents for reporting on functional and molecular tissue processes in-vivo opens new ways for detecting disease, characterizing cellular and sub-cellular processes and for assessing the effects of treatments. With this increased capacity for visualization conies a pressing need for highly advanced imaging technology that can accurately resolve in three dimensions and quantify the bio-distribution of such fluorochromes through dense tissues. Fluorescence macroscopy of entire animals and tissues is a most challenging and still largely unexplored field of imaging sciences, whose full potential is far from being reached. This proposal offers to develop a hybrid FMT system that combines the most advanced current developments on optical tomography with high-resolution X-ray Computed Tomography to offer unprecedented imaging capacity for small animal imaging. The system proposed is a fundamentally new design that assumes complete projection (360 degrees) illumination and detection, similarly to geometrical practices seen in X-ray CT. A CCD camera is used for obtaining high spatial sampling photon collection in the absence of previously utilized matching fluids or fibers in physical contact with tissue. As such, the proposed design and methods are not simply an incremental step forward compared to previous implementations but offer a new generation in terms of performance and experimental simplicity. While we expect the technology to find many small animal imaging applications, we are particularly interested in applying it for improving imaging in mouse models of cancer. We hypothesize that the proposed developments will yield a practical and highly efficient system that can become a method of choice in many preclinical studies involving in-vivo imaging of entire animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioorthogonal probe development for highly parallel in vivo imaging
-
批准号:10596786
-
项目类别:
-
资助金额:$41.58万
-
财政年份:2023
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapy
-
批准号:10704328
-
项目类别:
-
资助金额:$57.73万
-
财政年份:2023
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
-
批准号:10615899
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2020
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
-
批准号:10403494
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2020
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Single Circulating Vesicle Analysis for Early Cancer Detection
-
批准号:9913496
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2019
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Imaging of nanotherapeutic drug action
-
批准号:9261150
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2017
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Multiplexed analysis of exosomes in cancer nano therapy
-
批准号:9078198
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2016
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Multiplexed analysis of exosomes in cancer nano therapy
-
批准号:9487955
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2016
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Analysis of scant cancer cells in fine needle aspirates
-
批准号:9023623
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2016
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Analysis of scant cancer cells in fine needle aspirates
-
批准号:9324962
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2016
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Single Cell Imaging of the Heart
-
批准号:9265709
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2014
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Single Cell Imaging of the Heart
-
批准号:9049540
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2014
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Single Cell Imaging of the Heart
-
批准号:8667532
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2014
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Single Cell Imaging of the Heart
-
批准号:8843950
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2014
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Whole Genome Amplification and Sequencing of Single Cancer Cells
-
批准号:8624939
-
项目类别:
-
资助金额:$43.69万
-
财政年份:2013
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Whole Genome Amplification and Sequencing of Single Cancer Cells
-
批准号:8740473
-
项目类别:
-
资助金额:$40.69万
-
财政年份:2013
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Whole Genome Amplification and Sequencing of Single Cancer Cells
-
批准号:8909080
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2013
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Quantitative analysis of pharmacological mechanism by intravital imaging
-
批准号:8902052
-
项目类别:
-
资助金额:$80.86万
-
财政年份:2011
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
Quantitative analysis of pharmacological mechanism by intravital imaging
-
批准号:8703640
-
项目类别:
-
资助金额:$78.43万
-
财政年份:2011
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
MOLECULAR IMAGING CORE
-
批准号:8052118
-
项目类别:
-
资助金额:$55.46万
-
财政年份:2011
-
负责人:RALPH WEISSLEDER, MD, PHD
-
依托单位:
海外基金